APPLICATION
ANDA040249
TYPE
ANDA
ORIGINAL APPROVAL
1999-01-29
LATEST ACTION
2024-06-14
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Prescription
Products
ORPHENADRINE CITRATEPrescription
ORPHENADRINE CITRATE 100MG · TABLET, EXTENDED RELEASE · ORAL
Approval history
2024-06-14Labeling · Supplement 4 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.